Article Text

Download PDFPDF

Is intestinal metaplasia of the stomach reversible?
  1. M M Walker
  1. Correspondence to:
    M M Walker, Department of Histopathology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, St Mary’s Campus, Norfolk Place, London W2 1PG, UK; mm.walker{at}ic.ac.uk

Abstract

Intestinal metaplasia (IM) of the stomach is a risk factor in developing intestinal-type gastric cancer and hence the question of reversibility is vital. There is emerging epidemiological evidence that with long term follow up, IM may be reversible although a combination of antioxidant agents and eradication of H pylori may be necessary to achieve this. The pathogenesis of IM is currently being elucidated and it is likely that a combination of bacterial, host, and environmental factors will be shown to lead to IM. In assessing gastric cancer risk, histochemical typing of IM will most probably be replaced by molecular markers.

  • Helicobacter pylori
  • intestinal metaplasia
  • biopsy
  • endoscopy
  • IM, intestinal metaplasia
  • COX-2, cyclooxygenase 2
  • MSI, microsatellite instability
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles